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a b s t r a c t
Background: COVID-19 initially caused less severe outbreaks in many low- and middle-income countries (LMIC) compared with many high-income countries, possibly because of differing demographics,
socioeconomics, surveillance, and policy responses. Here, we investigate the role of multiple factors on
COVID-19 dynamics in the Philippines, a LMIC that has had a relatively severe COVID-19 outbreak.
Methods: We applied an age-structured compartmental model that incorporated time-varying mobility,
testing, and personal protective behaviors (through a “Minimum Health Standards” policy, MHS) to represent the ﬁrst wave of the Philippines COVID-19 epidemic nationally and for three highly affected regions
(Calabarzon, Central Visayas, and the National Capital Region). We estimated effects of control measures,
key epidemiological parameters, and interventions.
Findings: Population age structure, contact rates, mobility, testing, and MHS were suﬃcient to explain the
Philippines epidemic based on the good ﬁt between modelled and reported cases, hospitalisations, and
deaths. The model indicated that MHS reduced the probability of transmission per contact by 13-27%.
The February 2021 case detection rate was estimated at ~8%, population recovered at ~9%, and scenario
projections indicated high sensitivity to MHS adherence.
Interpretation: COVID-19 dynamics in the Philippines are driven by age, contact structure, mobility, and
MHS adherence. Continued compliance with low-cost MHS should help the Philippines control the epidemic until vaccines are widely distributed, but disease resurgence may be occurring due to a combination of low population immunity and detection rates and new variants of concern.
Funding: This work was supported by the World Health Organization Regional Oﬃce for the Western
Paciﬁc. Tagalog translation of the abstract (Appendix 2).
© 2021 Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND IGO license
(http://creativecommons.org/licenses/by-nc-nd/3.0/igo/)

Abbreviations: CDR, Case detection rate; COVID-19, Coronavirus disease 2019; HIC, High-income countries; ICU, Intensive care unit; LMIC, Low- and middle-income countries; MHS, Minimum Health Standards; NPI, Non-pharmaceutical intervention.
✩
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cal climates may reduce COVID-19 transmission and severe disease in many LMIC3–5 , while high contact rates, high prevalence
of comorbidities, high population densities, and limited healthcare
capacity could increase burden6–10 . While many LMIC have had
lower COVID-19 burdens than HIC, weak surveillance systems11
could also affect epidemic estimates. Nonetheless, understanding
why many LMIC have had apparently less severe outbreaks could
help other countries better control their epidemics until vaccines
are widely distributed.
While there are now several highly eﬃcacious vaccines to prevent severe disease12 , 13 , and possibly infection14 , 15 , from SARSCoV-2 (the virus that causes COVID-19), widespread vaccination
will take months to years16 , 17 and will likely need to be coupled
with effective non-pharmaceutical interventions (NPIs)18 . For countries rolling out vaccines, easing NPIs too early could jeopardize
success18 . However, for the majority of the world’s population, particularly those living in LMIC, vaccine access and delivery is limited19 and widespread vaccination coverage may take two or more
years17 , 20 . Thus, with or without vaccines, understanding the effectiveness of NPIs that can curtail COVID-19 transmission is critical. There are three broad categories of NPIs, those that aim to: (i)
isolate infected individuals and their contacts; (ii) reduce contact
between infected and susceptible people (henceforward “macrodistancing”); and (iii) reduce transmission given contact between infected and susceptible people (henceforward “microdistancing”).
Most HIC have enforced initiatives for all three types of NPIs with
a focus on long, strict macrodistancing interventions through stayat-home orders. LMIC have also employed macrodistancing policies but often with shorter, less strict orders because these types
of initiatives exacerbate poverty and have societal costs21 , 22 that
LMIC cannot withstand (although some LMIC like China enforced
strict, short-term macrodistancing policies that led to successful
disease suppression). Relaxing of short-term macrodistancing policies would be expected to lead to disease resurgence23 , which runs
counter to the experience of some LMIC. A meta-analysis indicates
that inexpensive microdistancing policies (e.g., properly wearing
face masks) can be highly effective24 and therefore could explain
why some LMIC are continuing to suppress transmission after an
initial period of macrodistancing.
The Philippines is one of the most severely affected countries
by COVID-19 in the Western Paciﬁc Region25–27 . Here we investigate COVID-19 epidemiology in the Philippines during the ﬁrst
wave of transmission and the effectiveness and sensitivity to microdistancing policies. The Philippines is a LMIC that, during the
ﬁrst epidemic wave, had over 580,0 0 0 conﬁrmed cases and more
than 12,0 0 0 deaths, with a peak in incidence in August 2020; at
time of writing, the Philippines is undergoing a subsequent second, more severe wave of transmission that is not assessed in this
study. Various NPIs have been implemented in the country, with
the timing and level of restriction varying by region. The NPIs implemented include different levels of community quarantines, including school closures28 . Between October 2020 and March 2021,
the Philippines shifted from a focus on community quarantine orders towards greater reliance on Minimum Health Standards (MHS)
policies, requiring the proper use of face coverings, physical distancing, and hand hygiene. To gain insights into the Philippines
epidemic during the ﬁrst wave of transmission, we present a datadriven COVID-19 model, which includes age structure, heterogeneous contact patterns, time-varying testing rates, and macro- and
microdistancing. We use this model to 1) estimate epidemiological
parameters for COVID-19 in the Philippines; 2) consider the effects
of NPIs implemented during the ﬁrst wave of transmission; and 3)
create scenarios for various policy changes and estimate associated
risk of disease resurgence.

Research in context
Evidence before this study
The ongoing COVID-19 pandemic has affected more than
188 countries with variable impacts across settings, and apparently less severe outbreaks initially in many low- and
middle-income countries (LMIC) compared with many high
income countries. Understanding the reasons for these differences is critical in determining how to ease restrictive nonpharmaceutical interventions (NPIs) without causing disease
resurgence until vaccines are widely distributed. There are
numerous factors that could drive these differences across
countries, including population age structure, contact patterns, population density, seasonality, pre-existing exposure
to other coronaviruses, comorbidities associated with poorer
COVID-19 outcomes, healthcare and testing capacity, and intervention policies. Previous studies suggest that in LMIC, any
beneﬁts from factors like younger populations (due to lower
susceptibility and infectiousness) may be negated by factors
such as limitations in surveillance and healthcare capacity. If
true, NPI timing and stringency could be expected to explain
differences in COVID-19 burden across income settings.
Added value of this study
We explored the extent to which age structure, contact
patterns, changes in mobility and personal protective behaviors have driven the COVID-19 epidemic in the Philippines
using a compartmental model and considered scenarios for
future disease burden with policy changes. The model indicated that COVID-19 epidemiology in the Philippines can be
explained by age, contact structure, mobility, and adherence
to public health policies. The Minimum Health Standards policy, which requires people to adopt a suite of personal protective behaviors, has played a substantial role in reducing
transmission in the Philippines. However, low testing capacity, the limited proportion of the population recovered from
infection (modelled), and high sensitivity to easing policies,
are likely to be important factors in determining the potential for disease resurgence.
Implications of all the available evidence
Age and contact structures likely drive the substantial
differences in COVID-19 burdens across income settings,
but low-cost interventions can limit disease burden further.
While numerous demographic, political, and socioeconomic
factors are hypothesised to affect disease transmission, the
results of this study suggest that, prior to the introduction
of variants of concern, the apparent lower burden of disease in the Philippines was driven by younger populations,
contact structure, and policy. Using the Philippines as a case
study, which experienced a relatively severe COVID-19 outbreak for a LMIC, we investigated the effectiveness of NPIs
and personal protective behaviors in curtailing transmission
and found that personal protective behaviors have likely reduced disease burden considerably. This study therefore provides evidence of a low-cost, effective intervention policy
that could be adopted by other countries to prevent disease
resurgence while vaccines are distributed.

INTRODUCTION
Coronavirus disease of 2019 (COVID-19) epidemiology differs
across settings with apparently less severe initial outbreaks in
many low- and middle-income countries (LMIC) compared with
many high income countries (HIC)1 , 2 , such that understanding why
LMIC are less affected is critical to understanding global epidemiology. Multiple demographic and socioeconomic factors likely drive
differential COVID-19 burden across income groups, both within
and among countries. Expansive population pyramids and tropi-
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Figure 1. Age-structured COVID-19 model informed with population size, contact rates, and mobility from the Philippines. (A) Starting population age distribution used in the
Philippines national model. (B) Unstratiﬁed model structure, coloured by infectious state (blue = non-infectious; pink = moderately infectious; red = highly infectious). (C)
Stratiﬁcation by infection and detection status (same colour scheme as in A) for actively infectious exposed and infected compartments. (D) Heterogeneous mixing matrices
by age in the absence of NPIs (brighter colours indicate higher average number of contacts per day). (E) Community quarantine driven mobility adjustments applied to the
mixing matrices (before seven-day moving average smoothing). Other locations include average from retail and recreation, supermarket and pharmacy, parks, and public
transport. We provide panels A and E for the regional models in Fig. S4.

METHODS

Model

Data

We developed an age-structured deterministic compartmental
model of SARS-CoV-2 viral transmission to model disease spread
in the Philippines. We included six sequential compartments in
the model representing susceptible, non-infectious exposed, infectious exposed, early actively infectious, late actively infectious, and
recovered/removed persons (Figs. 1B, S1; Table 1), and stratiﬁed
the infectious compartments by detection status and disease severity (Figs. 1C, S2-3; we show differential equations in supplemental material). Similar SEEIIR model frameworks have been used for
other studies on COVID-1929 , 30 and inﬂuenza31 . To account for agedependent processes, we stratiﬁed all model compartments by age
group using 5-year age bands from birth to ≥75 years of age and
allowed the proportion symptomatic, susceptibility to infection, infection fatality rate, and the probability of hospitalisation to differ
by age group. To introduce heterogeneous mixing by age, we incorporated synthetic mixing matrices developed by Prem et al. 201732
(Fig. 1D).
We considered several inter-compartmental transition rates to
represent epidemiologically important processes. To estimate disease incidence, detected cases, hospitalisation, and ICU admission
rates, we quantiﬁed transitions between different exposed and infectious compartments within the model (Fig. 1B-C, supplemental material). To calculate a modelled case detection rate, we calculated the proportion of symptomatic cases that were detected
(Fig. 1C). We related the case detection rate (CDRt where t = time)
to the daily number of per capita tests performed using an exponential function, under the assumption that a certain testing rate is
associated with a speciﬁc case detection rate (with this parameter

We used several data sources from the Philippines to assess
COVID-19 epidemiology at the national level and for three highly
affected regions: Calabarzon (Region IV-A), Central Visayas (Region
VII), and the National Capital Region (Metro Manila). For national
and regional population data, we used the 2020 projected population distribution by age from the Philippines Statistics Authority
(Figs. 1A, S4). To gain insight into the ﬁrst wave of transmission in
the Philippines, we used time series data from 1 March 2020 to 23
February 2021. We aggregated these data across all age groups (for
data sources where age was available), because data were sparse
for certain age groups and >20 0 0 records were missing age information. For number of tests, ICU occupancy, and deaths, we
used daily data from the Republic of the Philippines Department
of Health COVID-19 Data Drop (https://doh.gov.ph/covid19tracker).
We aggregated test data from multiple laboratories (we list the
laboratory facilities associated with each region in Table S6). For
daily conﬁrmed cases, we used the Department of Health COVID19 Philippines Local Government Units Monitoring Platform (https:
//fassster.ehealth.ph/covid19/). Lab facilities in the Philippines conﬁrmed cases by RT-PCR and we calculated daily cases based on report date. To account for differences between weekday and weekend reporting, we smoothed daily conﬁrmed cases using a seven
day moving average. To quantify changing mobility patterns associated with NPIs, we used Google mobility data (https://www.google.
com/covid19/mobility/).
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Table 1
Compartments of the epidemiological model, indicating the stage of infection for different proportions of the population.
Compartment
S
En
Ei
Ie
Il
R

Deﬁnition
Susceptible to infection.
Non-infectious exposed, representing infected individuals in the non-infectious phase of the incubation period.
Infectious exposed, representing infected individuals in the “presymptomatic” phase of the incubation period where onward transmission can occur.
Early actively infectious, individuals are transmitting disease but not (yet) detected.
Late actively infectious, symptomatic individuals are detected (for those whom detection does occur) and isolation and hospitalisation occurs.
Recovered and removed (i.e., dead).

Table 2
Key parameter prior and posterior distributions from the Philippines model. All parameters with the term “adjuster” allow for modiﬁcation to the best estimates
from the literature. Adjuster values are multiplicative factors applied to the odds ratio. An adjuster value of one indicates no adjustment is needed, a value
below one indicates the parameter is lower in the Philippines, and a value above one indicates the parameter is higher in the Philippines. MHS is the Minimum
Health Standards and refers to the microdistancing function that proportionally reduces the probability of transmission given contact.
Parameter

Prior distribution

Prior distribution parameters

Incubation period (days)

Truncated normal

Duration actively infectious (days)

Truncated normal

5.19

6.49

7.95

Infection risk per contact
Symptomatic proportion adjuster
Infection fatality adjuster
hospitalisation proportion adjuster
Maximum effect of MHS (proportion)
Case Detection Rate at testing rate of
1 test per 10,000 per day (proportion)
Infectious seed (persons)

Uniform
Uniform
Uniform
Uniform
Uniform
Uniform

Mean 5.5, standard deviation 0.97, truncated
range [1, inﬁnity)
Mean 6.5, standard deviation 0.77, truncated
range [4, inﬁnity)
Range 0.02-0.04
Range 0.5-2.0
Range 0.5-2.0
Range 0.5-2.0
Range 0.1-0.6
Range 2-20

0.029
0.589
0529
0.588
0.13
2.88%

0.033
1.23
1.07
1.34
0.20
9.81%

0.038
1.91
1.91
1.96
0.27
19.3%

Uniform

Range 10-100

17.80

71.50

97.90

varied in calibration):

CDRt = 1 − ex p

Posterior credible interval centiles
2.5th
50th
97.5th
3.70
5.42
7.36

ICU occupancy and cumulative deaths (806 and 11523 respectively
for the national model). Although we calibrated the model to these
three targets simultaneously, we prioritized conﬁrmed cases in the
calibration process because these data are considered the highest
quality in the Philippines for COVID-19 (based on advice from local
health oﬃcials), while limiting the use of ICU and mortality data
to the most recent values, as the quality of these data improved
over time. We simultaneously ﬁt the model to the three calibration targets using an adaptive Metropolis algorithm33 (Table 2;
supplemental material). For the prior distributions of epidemiological calibration parameters, we used uniform priors for highly
uncertain quantities and truncated normal distributions for quantities informed by epidemiological evidence (Table 2; supplemental material). To account for potential differences between HIC and
LMIC, we included “adjuster” parameters to modify the proportion
of symptomatic individuals, proportion of symptomatic individuals hospitalised, and the infection fatality rate (which are based on
estimates from HIC). The adjuster values are multiplicative factors
applied to the odds ratio, where an adjuster value of one would
indicate no adjustment is needed, a value below one would indicate the parameter is lower in the Philippines, and a value above
one would indicate the parameter is higher in the Philippines. To
calibrate the model, we ran seven independent chains with approximately 10 0 0 0 iterations per chain and discarded the ﬁrst 200
iterations as burn-in. We evaluated convergence and autocorrelation through visual inspection of trace plots and autocorrelograms
respectively, and calculated effective sample sizes. We used Latin
Hypercube Sampling across the multidimensional parameter space
to select initial parameter conditions. We structured the model,
calibration data, likelihood function, and priors identically for the
national and regional models. We report the model outputs as
median estimates with 25-75 and 2.5-97.5 credible interval percentiles to show uncertainty.

−b∗ testst
10,0 0 0

Non-pharmaceutical interventions
We simulated community quarantines (e.g., business closures
and working from home) by varying the relative contribution of
four locations to an overall age-speciﬁc dynamic mixing matrix
(Figs. 1D). Using Google mobility data, we scaled the household
contribution to the matrix with residential mobility; the work contribution with workplace mobility; and the contribution from other
locations (contacts outside of schools, homes, and work) with average mobility from all other Google mobility locations (Fig. 1E,
S4). We simulated school closures by scaling school contribution
according to the proportion of children attending schools under
relevant policies. When schools closed, home contacts scaled up
with residential Google mobility data, although in reality, scaling
up home contacts beyond the average household size may not
strongly affect transmission due to contact saturation (i.e., the ceiling effect of the limited number of potential contacts to infect
within each household). In the Philippines, school closures started
in mid-March 2020 in the most highly affected areas and schools
remain closed throughout the country (as of 10th May 2021).
We simulated MHS as a scaled function that proportionally reduces the probability of transmission given contact (reducing the
probability of an infected person passing on the infection and the
probability of a contact being infected). We allowed the function to
scale from zero when we assumed minimal compliance with MHS
(15th August 2020) to a maximum value estimated by the calibration process (described below) when MHS was widely adopted
(15th November 2020).
Calibration
We calibrated the model to data to reproduce local COVID-19
dynamics and evaluated estimations of key epidemiological parameters (Table 2). We used three sources of local data as calibration
targets: total daily conﬁrmed cases and the most recent estimate of

Scenarios
We ran scenarios with different policy changes to estimate future COVID-19 transmission and potential for disease resurgence
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with easing different interventions. The baseline scenario held mobility and MHS constant based on the most recent date of data
(26th February 2021) through the end of the scenario period (31st
December 2021). All scenarios began on 27th February 2021. We
simulated 50% return of onsite workers by increasing the relative
contribution of workplace mobility in the overall age-speciﬁc mixing matrix from current levels to current levels plus half the difference between current workplace mobility and pre-COVID workplace mobility. We simulated school reopenings by scaling school
contribution in the overall age-speciﬁc mixing matrix from zero to
one on the scenario start date to reﬂect full school attendance. To
estimate the effect of easing MHS by 50, 70, and 100%, we decreased the microdistancing function, which reduces the values of
all elements of the mixing matrices by a certain proportion, to 0.5,
0.3, and 0.0, respectively. We report the scenarios as median values
with 25-75 and 2.5-97.5 percentiles to show uncertainty.

the risk of transmission per contact by about 20%. The model case
detection was estimated at approximately 2 to 15% in the Philippines (Fig. S14), although the posterior distribution of this value
was broad (Fig. S13).
Scenario projections
We projected transmission in the near term under a range
of possible scenarios and show that, prior to the second epidemic wave, epidemic trajectories were highly sensitive to compliance with MHS. Moreover, allowing home workers to return onsite while maintaining MHS was estimated to have limited impact on detected cases (Figs. 5, S15-17), as well as overall incidence, hospital occupancy, and mortality (although the projections
did not account for potentially increased transmission within contained spaces during the work week). If current conditions were
carried forward, transmission was projected to continue at low levels and therefore would not overwhelm hospital capacity or lead
to excessive deaths. Allowing students to return to school was estimated to result in a considerable increase in cases (although this
result varied markedly by region, Figs. S15-17). Reducing the effectiveness of MHS by 50% was projected to lead to a steady increase
in burden, whereas reducing the effectiveness of MHS by 70% or
100% was projected to lead to a major resurgence in cases, associated hospitalisations, and deaths.

Role of the funding source
The funding source of this study facilitated collaboration,
helped to deﬁne the research questions, and assisted with interpretation, but had no role in model development, parameterisation,
and methodological aspects of the study.
RESULTS
Epidemiological ﬁt

DISCUSSION
The model reproduced national and regional trends in conﬁrmed cases, hospitalisations, and deaths when incorporating
changes in movement and adherence to MHS. Prior to assessing
model ﬁt to data, we determined that the model converged by visually assessing trace plots (e.g., Fig S5 for parameters in the national model) and calculated effective sample sizes of 1170 for the
national model, 869 for Calabarzon, 1139 for Central Visayas, and
1513 for the National Capital Region. The model ﬁt was considerably better with the inclusion of both community quarantineadjusted movement and adherence to MHS compared with a
counterfactual scenario that only included community quarantines
(Figs. 2, S6-8). These results suggest that if MHS had not been implemented, there would have been twelve times as many cases at
the August 2020 outbreak peak. The four calibrated models (national and three regional models) show reasonably good ﬁts to total conﬁrmed cases (Figs. 2-3). Additionally, the distributions are
similar for modelled and conﬁrmed cumulative cases by age group,
with very close correspondence for those aged 40 years and above,
but underpredictions for those aged 25-39 and overpredictions for
ages 19 and below (Fig. S9). The models slightly overpredict reported cumulative deaths and ICU occupancy (except for the National Capital Region) (Figs. 4, S10-12). We estimated the proportion of the population recovered by the end of the ﬁrst wave of
transmission as approximately 9% (95% CI = 4-31%) as of 26th
February 2021 (Fig. 4).

The combination of younger age distributions, more intergenerational contacts, changes in mobility, and changes in personal protective behaviors, appear to explain why the Philippines sustained
a relatively less severe COVID-19 outbreak than many high income countries (HIC), prior to the introduction of variants of concern34 , 35 . Younger populations typical of LMIC may reduce disease
burden in two ways: 1) a proportionally smaller percent of the
population is elderly (compared with HIC) and at highest risk of
severe disease and mortality from COVID-193 , 4 ; and 2) those who
survive to old age are often of higher socioeconomic status and
may have a disproportionately lower infection risk compared with
the general population36 . More intergenerational contacts in LMIC
may also lower disease burden because elderly people often reside
with family rather than in aged-care facilities, which have driven
outbreak clusters in many HIC (e.g., [37]). An important ﬁnding of
this study is that adherence to MHS appeared largely responsible
for limiting transmission in the Philippines while gradually easing quarantines during the ﬁrst epidemic wave. These results were
consistent across regions (i.e., all models presented in this paper)
that span a wide population density gradient, suggesting that this
approach is effective in both rural and urban areas and could also
be effective in other similar settings. It is possible that the effect of
MHS is a surrogate for other time-varying processes, however, local
experts within the Philippines provide strong intuition that MHS is
responsible for driving the patterns we found. In addition, we are
not aware of any other processes than those modelled that could
be responsible for these patterns. These types of personal protective measures will likely continue to be needed throughout 2021
and potentially 2022, depending on the speed of vaccine distribution.
Current transmission trends in the Philippines (as of 10th
May 2021) indicate that the country is in the middle of a second, larger wave of transmission and sustained disease spread remains a major threat until vaccines are widely distributed. Local expert opinion suggests the second wave is mainly occurring
in the National Capital Region and parts of Calabarzon and are
driven by new variants of concern34 , which are more transmissible

Parameter and case detection estimation
We estimated key epidemiological parameters and transition
rates (Table 2; Fig. S13). We incorporated parameters to adjust the
proportion of symptomatic individuals, the proportion of symptomatic individuals hospitalised, and the infection fatality rate
from the baseline values and estimated all three adjuster parameters had broad distributions overlapping one, indicating that the
process of ﬁtting to data did not provide information on the adjustments needed to these quantities. The maximum effect of MHS
was estimated at around 0.20 (95% CI = 0.12 - 0.27) with a tight
posterior distribution (Fig. S13), suggesting that MHS has reduced
5
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Figure 2. Model reproduced daily conﬁrmed case count better with the inclusion of Minimum Health Standards (MHS). We calibrated the national model to daily conﬁrmed
cases (black dots; same in both plots), which included MHS (left) and ran a counterfactual scenario that did not include MHS (right). The MHS effect value (i.e., reduced
transmission risk per contact) is squared in the model to account for the reduction in the probability of an infected person passing on the infection and the probability of a
contact being infected, prior to adjustment of each cell of the mixing matrix. We provide results for the regional models with and without MHS in Figs. S6-8.

Figure 3. Model ﬁt to conﬁrmed cases in three regions of the Philippines, which varied in magnitude.

and lethal38 . Further, increases in mobility, due to relaxed interzonal travel requirements, and lower compliance to MHS (which
could be attributable to over-conﬁdence in disease control and fatigue with personal protective behaviors), provides more transmission opportunities. The results of this study provided real-time
weekly updates of the model outputs through the ﬁrst wave directly to policy-makers through the Department of Health COVID19 Philippines Local Government Units Monitoring Platform (https:
//fassster.ehealth.ph/covid19/) and indicated that, in the absence
of new variants, relaxing societal restrictions like work-from-home
orders were not predicted to cause substantial disease resurgence.
At the same time, low case detection (2-15%) and percentage recovered (modelled at <31%) and high sensitivity to maintaining
MHS indicated that disease resurgence remained a major threat.
Thus, prior to the introduction of disease variants, MHS may have
been suﬃcient to sustain suppression of transmission as a bridge
to broad scale vaccination. Although not modelled in this study,
the increased transmissibility of the new variants may be broadly
comparable to the reduction in transmission gained by MHS adherence. Therefore, these measures may no longer be suﬃcient to
suppress transmission as strain replacement occurs, although they

would still help alleviate burden on the health care system. Recent disease resurgence in the Philippines demonstrates the need
for sustained non-pharmaceutical interventions until vaccines are
widely distributed. Limited testing is another major obstacle for
the Philippines39 and many other LMIC and can hinder both public
health response and our understanding of the epidemic.
There are several important limitations relevant to interpreting the model results, including modelling assumptions, data limitations, and uncertainty. Most epidemiological parameters for
COVID-19 used in this study were estimated from HIC (or China).
While we included “adjuster” parameters to allow the symptomatic
proportion, hospitalisation, and mortality rates to vary for the
Philippines (similar to [40]), these parameters were not well constrained by the data. We assumed that other parameters were similar to HIC, which may be inaccurate. However, most parameter
estimates appear reasonable given previously reported COVID-19
epidemiology in the Philippines26 . When more data become available from the Philippines or similar settings, the current model
can be updated with new parameter values. Data issues made
modelling and understanding the epidemic in the Philippines particularly challenging, although data quality has progressively im-
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Figure 4. Model estimated epidemic indices from the calibrated Philippines model. Note that only the most recent estimate of cumulative deaths and ICU occupancy were
included in the likelihood function, with the other time points presented as validation. ICU occupancy data was considered to have improved over the course of the epidemic.
We provide equivalent regional model outputs in Figs. S10-12.

Figure 5. Epidemic scenario projections for detected cases from the Philippines national model, showing high sensitivity to compliance with the Minimum Health Standards
(MHS). We provide epidemic scenario projections for the regional models in Figs. S15-17.

proved through time. For example, additional ICU facilities were
created speciﬁcally for COVID-19 in the Philippines and were not
required to report usage, likely affecting these estimates, especially
early in the epidemic. Similarly, daily deaths, which are often considered the most reliable epidemic indicator internationally, have
ﬂuctuated markedly over the course of the epidemic, often peaking at times that appear contradictory to patterns of conﬁrmed
cases. Although reporting of daily deaths appears unreliable, cumulative deaths align reasonably well with the model projections
of mortality without signiﬁcant modiﬁcation to the internationally estimated infection fatality rate. Finally, there is uncertainty
around all model parameters, with some parameters less well constrained than others (e.g., case detection rate), which highlights the

need for more epidemiological information. Future studies could
build on this effort by including new, more robust data sources for
model parameters and calibration targets.
CONCLUSION
One of the most critical issues facing countries around the
world is determining the best strategy for ending COVID-19
transmission through the combined use of vaccines and nonpharmaceutical interventions. More than 188 countries have been
affected by COVID-19 with apparently less severe impacts in many
LMIC compared with HIC. Our results suggest that COVID-19 epidemiology in the Philippines can be explained by differences in
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age, contact structures, and policy, with MHS playing a substantial
role in mitigating the initial outbreak. The Philippines has experienced one of the largest outbreaks of COVID-19 in the Western
Paciﬁc Region but also provides an approach that could help other
countries relax interventions more safely, which remains an important strategy for countries with limited access to vaccines.
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